Literature DB >> 20336402

Emerging strategies for the identification and targeting of cancer stem cells.

Jun Dou1, Ning Gu.   

Abstract

The hypothesis of cancer stem cells (CSCs) is receiving increasing interest and has become the subject of considerable debate among cancer researchers. Recent rapid progress in CSC research has encountered increasing difficulties and challenges. Understanding the biologic characteristic of CSCs is crucial to start with better identification and diagnosis based on CSC markers and eventually targeting to CSCs will undoubtedly result in improved prevention and treatment of many types of CSCs. We discuss here some of the approaching strategies that include establishing special methods of identifying CSCs and targeting therapies of CSCs.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20336402     DOI: 10.1007/s13277-010-0023-y

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  98 in total

1.  3D collagen cultures under well-defined dynamic strain: a novel strain device with a porous elastomeric support.

Authors:  Alice A Tomei; Federica Boschetti; Francesca Gervaso; Melody A Swartz
Journal:  Biotechnol Bioeng       Date:  2009-05-01       Impact factor: 4.530

2.  Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells.

Authors:  Yohei Shimono; Maider Zabala; Robert W Cho; Neethan Lobo; Piero Dalerba; Dalong Qian; Maximilian Diehn; Huiping Liu; Sarita P Panula; Eric Chiao; Frederick M Dirbas; George Somlo; Renee A Reijo Pera; Kaiqin Lao; Michael F Clarke
Journal:  Cell       Date:  2009-08-07       Impact factor: 41.582

Review 3.  Opinion: migrating cancer stem cells - an integrated concept of malignant tumour progression.

Authors:  Thomas Brabletz; Andreas Jung; Simone Spaderna; Falk Hlubek; Thomas Kirchner
Journal:  Nat Rev Cancer       Date:  2005-09       Impact factor: 60.716

4.  Identification of cells initiating human melanomas.

Authors:  Tobias Schatton; George F Murphy; Natasha Y Frank; Kazuhiro Yamaura; Ana Maria Waaga-Gasser; Martin Gasser; Qian Zhan; Stefan Jordan; Lyn M Duncan; Carsten Weishaupt; Robert C Fuhlbrigge; Thomas S Kupper; Mohamed H Sayegh; Markus H Frank
Journal:  Nature       Date:  2008-01-17       Impact factor: 49.962

Review 5.  Cancer stem cells and human malignant melanoma.

Authors:  Tobias Schatton; Markus H Frank
Journal:  Pigment Cell Melanoma Res       Date:  2008-02       Impact factor: 4.693

6.  Ovarian normal and tumor-associated fibroblasts retain in vivo stromal characteristics in a 3-D matrix-dependent manner.

Authors:  Roderick M Quiros; Matthildi Valianou; Youngjoo Kwon; Kimberly M Brown; Andrew K Godwin; Edna Cukierman
Journal:  Gynecol Oncol       Date:  2008-05-02       Impact factor: 5.482

Review 7.  CD133: molecule of the moment.

Authors:  D Mizrak; M Brittan; M R Alison
Journal:  J Pathol       Date:  2008-01       Impact factor: 7.996

Review 8.  Brain tumour stem cells: possibilities of new therapeutic strategies.

Authors:  Sara G M Piccirillo; Angelo L Vescovi
Journal:  Expert Opin Biol Ther       Date:  2007-08       Impact factor: 4.388

9.  Effect of CD133/prominin-1 antisense oligodeoxynucleotide on in vitro growth characteristics of Huh-7 human hepatocarcinoma cells and U251 human glioma cells.

Authors:  Jie Yao; Tao Zhang; Jinghua Ren; Minxia Yu; Gang Wu
Journal:  Oncol Rep       Date:  2009-10       Impact factor: 3.906

Review 10.  Phenotypic diversity in experimental hepatomas: the concept of partially blocked ontogeny. The 10th Walter Hubert Lecture.

Authors:  V R Potter
Journal:  Br J Cancer       Date:  1978-07       Impact factor: 7.640

View more
  26 in total

Review 1.  Can nanomedicines kill cancer stem cells?

Authors:  Yi Zhao; Daria Y Alakhova; Alexander V Kabanov
Journal:  Adv Drug Deliv Rev       Date:  2013-10-10       Impact factor: 15.470

2.  Antitumor efficacy of viable tumor vaccine modified by heterogenetic ESAT-6 antigen and cytokine IL-21 in melanomatous mouse.

Authors:  Xiangfeng He; Jing Wang; Fengshu Zhao; Fangliu Yu; Dengyu Chen; Kai Cai; Cuiping Yang; Junsong Chen; Jun Dou
Journal:  Immunol Res       Date:  2012-06       Impact factor: 2.829

3.  Evidence for embryonic stem-like signature and epithelial-mesenchymal transition features in the spheroid cells derived from lung adenocarcinoma.

Authors:  Raheleh Roudi; Zahra Madjd; Marzieh Ebrahimi; Ali Najafi; Alireza Korourian; Ahmad Shariftabrizi; Ali Samadikuchaksaraei
Journal:  Tumour Biol       Date:  2016-04-05

Review 4.  Cancer stem cell marker glycosylation: Nature, function and significance.

Authors:  Brody W Mallard; Joe Tiralongo
Journal:  Glycoconj J       Date:  2017-06-17       Impact factor: 2.916

5.  Antitumor efficacy induced by a B16F10 tumor cell vaccine treated with mitoxantrone alone or in combination with reserpine and verapamil in mice.

Authors:  Xiangfeng He; Jing Wang; Jun Dou; Fangliu Yu; Kai Cai; Xiaoli Li; Hongyi Zhang; Ning Gu
Journal:  Exp Ther Med       Date:  2011-06-14       Impact factor: 2.447

Review 6.  Nanoparticle delivery systems, general approaches, and their implementation in multiple myeloma.

Authors:  Pilar de la Puente; Abdel Kareem Azab
Journal:  Eur J Haematol       Date:  2017-03-28       Impact factor: 2.997

7.  Colon cancer stem cells: Potential target for the treatment of colorectal cancer.

Authors:  Riya Gupta; Lokesh Kumar Bhatt; Thomas P Johnston; Kedar S Prabhavalkar
Journal:  Cancer Biol Ther       Date:  2019-05-03       Impact factor: 4.742

Review 8.  Colon cancer stem cells: controversies and perspectives.

Authors:  Maria Ausiliatrice Puglisi; Valentina Tesori; Wanda Lattanzi; Giovanni Battista Gasbarrini; Antonio Gasbarrini
Journal:  World J Gastroenterol       Date:  2013-05-28       Impact factor: 5.742

9.  Decreasing lncRNA HOTAIR expression inhibits human colorectal cancer stem cells.

Authors:  Jun Dou; Yaoyao Ni; Xiangfeng He; Di Wu; Miao Li; Songyan Wu; Rong Zhang; Mei Guo; Fengsu Zhao
Journal:  Am J Transl Res       Date:  2016-01-15       Impact factor: 4.060

10.  Cancer stem cell markers in head and neck squamous cell carcinoma.

Authors:  Aidan G Major; Luke P Pitty; Camile S Farah
Journal:  Stem Cells Int       Date:  2013-03-03       Impact factor: 5.443

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.